The direct effect of oral hypoglycaemic agents on glucose metabolism by adipose tissue.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002245:Carbon Dioxide / Q000096:biosynthesis; D002247:Carbon Isotopes; D002747:Chlorpropamide / Q000494:pharmacology*; D003864:Depression, Chemical; D004822:Epididymis / Q000187:drug effects / Q000378:metabolism; D005947:Glucose / Q000378:metabolism*; D066298:In Vitro Techniques; D007328:Insulin / Q000494:pharmacology; D008055:Lipids / Q000096:biosynthesis; D008297:Male; D010629:Phenformin / Q000494:pharmacology*; D051381:Rats; D013268:Stimulation, Chemical; D014044:Tolbutamide / Q000494:pharmacology*
D002247:Carbon Isotopes; D007328:Insulin; D008055:Lipids; D002245:Carbon Dioxide; D014044:Tolbutamide; D010629:Phenformin; D005947:Glucose; D002747:Chlorpropamide